29 April 2024, Rhineland-Palatinate, Ludwigshafen: Photo: Uwe Anspach/dpa (Photo by Uwe ... [+] Anspach/picture alliance via Getty Images)dpa/picture alliance via Getty ImagesWe believe that the pharmaceuticals giant Merck (NYSE: MRK) is currently a better pick over its peer, AbbVie stock. MRK stock trades at 14x forward earnings, versus 20x for ABBV. We think this gap in valuation will narrow in favor of Merck in the coming years, given its superior revenue growth and profitability. There is more to the co ...